Delivery Order SPE2DB22D1106-SPE2DB25FFAZ2
Award Date 7/31/25
Potential Completion Date 8/21/25
Potential Value $94K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,174.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for August 8, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $13,968.50 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on July 24, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as the prime contractor fulfilling this...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials, with performance to be completed by August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible contractors....
- The Defense Logistics Agency awarded a $43,134 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used in medical treatments. This non-set-aside competitive award was issued on August 14, 2025, with an ultimate completion date of September 5, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $93,868.32 by the Defense Logistics Agency's Medical Supply Chain for the supply of Xeomin 200 Unit Vials. The contract, awarded on August 7, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 28, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,117.48 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Xeomin 100 Unit Vials. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 28, 2025, and represents a child order under a larger contract vehicle. The award carries no set-aside designation, reflecting open...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Xeomin 100 Unit Vials with a ceiling value of $1,396.85 and an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $12,851.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. The contract, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The company...
- The Defense Logistics Agency awarded a delivery order valued at $7,263.62 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued on July 23, 2025, was competitively awarded without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp received a $13,409.76 delivery order from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for September 3, 2025. This firm fixed price contract award was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Xeomin is a botulinum toxin product used in medical and therapeutic applications, and this...